Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells

Cancer Investigation

Volumn 25, Issue 8, 2007, Pages 678-684

  Takizawa, Bayan T ^a   Uchio, Edward M ^a   Cohen, Justin J ^a   Wheeler, Marcia A ^a   Weiss, Robert M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bladder cancer; NF B; Survivin; TNF receptors

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ABELSON KINASE; CAFFEIC ACID PHENETHYL ESTER; CASPASE; CASPASE 2; CYTOCHROME C; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; SURVIVIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UROGENITAL TRACT TUMOR;

APOPTOSIS; CAFFEIC ACIDS; CELL LINE, TUMOR; CHROMONES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; NEOPLASM PROTEINS; NF-KAPPA B; PHENYLETHYL ALCOHOL; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 36849017406     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701600954     Document Type: Article

References (23)

1. Li, F.; Ambrosini, G.; Chu, E.Y.; Plescia, J.; Tognin, S.; Marchisio, P.C.; et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998, 396, 580-584.
2. Beltrami, E.; Plescia, J.; Wilkinson, J.C.; Duckett, C.S.; Altieri, D.C. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J. Biol. Chem. 2004, 279, 2077-2084.
3. Ambrosini, G.; Adida, C.; Altieri, D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med. 1997, 3, 917-921.
4. Swana, H.S.; Grossman, D.; Anthony, J.M.; Weiss, R.M.; Altieri, D.C. Tumor content of the anti-apoptosis molecule survivin and recurrence of bladder cancer. New Engl. J. Med. 1999, 341(6), 452-453.
5. Smith, S.D.; Wheeler, M.A.; Plescia, J.; Colberg, J.W.; Weiss, R.M.; Altieri, D.C. Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001, 285(8), 324-328.
6. Salz, W.; Eisenberg, D.; Plescia, J.; Garlick, D.S.; Weiss, R.M.; Wu, X.R.; et al. A survivin gene signature predicts aggressive tumor behavior. Cancer Res. 2005, 65(9), 3531-3534.
7. Ning, S.; Fuessel, S.; Kotzsch, M.; Kraemer, K.; Kappler, M.; Schmidt, U.; et al. siRNA mediated down-regulation of survivin inhibits bladder cancer cell growth. Internat. J. Oncol. 2004, 25(4), 1065-1071.
8. Carvalho, A.; Carmena, M.; Sambade, C.; Earnshaw, W.C.; Wheatley, S.P. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 2003, 116(pt 14), 2987-2998.
9. Pennati, M.; Binda, M.; Colella, G.; Zoppe, M.; Folini, M.; Vignati, S.; et al. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene 2004, 23(2), 386-394.
10. Wilson, J.; Balkwill, F. The role of cytokines in the epithelial cancer microenvironment. Semin. Can. Biol. 2002, 12(2), 113-120.
11. Luo, J.L.; Maeda, S.; Hsu, L.C.; Yagita, H.; Karin, M. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004, 6(3), 297-305.
12. Arnott, C.H.; Scott, K.A.; Moore, R.J.; Robinson, S.C.; Thompson, R.G.; Balkwill, F.R. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development. Oncogene 2004, 23(10), 1902-1910.
13. Knight, B.; Yeoh, G.C.; Husk, K.L.; Ly, T.; Abraham, L.J.; Yu, C.; et al. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exper. Med. 2000, 192(12), 1809-1818.
14. Enoksson, M.; Robertson, J.D.; Gogvadze, V.; Bu, P.; Kropotov, A.; Zhivotovsky, B.; et al. Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids. J. Biol. Chem. 2004, 279(48), 49575-49578.
15. Kataoka, T.; Holler, N.; Micheau, O.; Martinon, F.; Tinel, A.; Hofmann, K.; et al. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J. Biol. Chem. 2001, 276(22), 19548-19554.
16. Mitsiades, C.S.; Mitsiades, N.; Poulaki, V.; Schlossman, R.; Akiyama, M.; Chauhan, D.; et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 2002, 21(37), 5673-5683.
17. Asanuma, H.; Torigoe, T.; Kamiguchi, K.; Hirohashi, Y.; Ohmura, T.; Hirata, K.; et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005, 65(23), 11018-11025.
18. Kanda, N.; Seno, H.; Konda, Y.; Marusawa, H.; Kanai, M.; Nakajima, T.; et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004, 23(28), 4921-4929.
19. Shaul, Y.; Ben-Yehoyada, M. Role of c-Abl in the DNA damage stress response. Cell Res. 2005, 15(1), 33-35.
20. Kappler, M.; Bache, M.; Bartel, F.; Kotzsch, M.; Panian, M.; Wurl, P.; et al. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Thera. 2004, 11(3), 186-189.
21. Bouchier-Hayes, L.; Martin, S.J. CARD games in apoptosis and immunity. EMBO Reports 2002, 3(7), 616-621.
22. Karin, M.; Lin, A. NF-kappaB at the crossroads of life and death. Nature Immunol. 2002, 3(3), 221-227.
23. Fuessel, S.; Herrmann, J.; Ning, S.; Kotzsch, M.; Kraemer, K.; Schmidt, U.; et al. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Cancer Lett. 2006, 232(2), 243-254.